Adnexal Mass Clinical Trial
Official title:
The Use of International Ovarian Tumor Analysis and Assessment of Different Neoplasia in the Adnexa Model in Differentiating Malignant and Benign Adnexal Masses
All participants will be subjected to Serum measurements of CA-125 by the immunoradiometric assay, Ultrasound evaluation of the Adnexal masses which is described according to origin (ovarian/extraovarian); position (right/left/bilateral); number of lesions; type of lesions (unilocular/multilocular); size in three dimensions (longitudinal, anteroposterior and transverse diameters); intracystic fluid echogenicity; number of loculations; presence and size of septations (only thickest one of septations is considered); presence, number and size of solid papillary projections (largest thickness is considered); presence and size of the largest solid component (three diameters); presence and measurement of fluid volume in the posterior cul-de-sac and presence and location of lesions suggestive of metastases. Then surgical intervention will be done with pathological examination of the specimen
All participants will be subjected to Serum measurements of CA-125 by the immunoradiometric assay, Ultrasound evaluation of the Adnexal masses which is described according to origin (ovarian/extraovarian); position (right/left/bilateral); number of lesions; type of lesions (unilocular/multilocular); size in three dimensions (longitudinal, anteroposterior and transverse diameters); intracystic fluid echogenicity; number of loculations; presence and size of septations (only thickest one of septations is considered); presence, number and size of solid papillary projections (largest thickness is considered); presence and size of the largest solid component (three diameters); presence and measurement of fluid volume in the posterior cul-de-sac and presence and location of lesions suggestive of metastases. Then surgical intervention will be done with pathological examination of the specimen ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05815992 -
Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score
|
||
Completed |
NCT06366997 -
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
|
||
Completed |
NCT00987649 -
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
|
N/A | |
Completed |
NCT04260334 -
Preoperative Care In Ovarian Cancer Patients
|
N/A | |
Terminated |
NCT04668521 -
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
|
||
Recruiting |
NCT05842629 -
Improved Diagnosis of Ovarian Cancer
|
||
Recruiting |
NCT05974618 -
Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)
|
||
Terminated |
NCT04487405 -
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
|
||
Recruiting |
NCT05017246 -
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
|
Phase 2 | |
Not yet recruiting |
NCT05761275 -
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
|
N/A | |
Completed |
NCT01466049 -
New Biomarkers Evaluating Ovarian Cancer
|
N/A | |
Terminated |
NCT03485651 -
Natera Ovarian Cancer Detection Assay
|
||
Active, not recruiting |
NCT04051502 -
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
|
||
Recruiting |
NCT05051722 -
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
|
||
Completed |
NCT03593681 -
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
|
||
Completed |
NCT02520115 -
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
|
Phase 1 | |
Recruiting |
NCT05461872 -
Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES
|
||
Completed |
NCT03297112 -
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
|
Early Phase 1 | |
Completed |
NCT03837327 -
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
|